SCHEMBL27273111

SCHEMBL27273111

COc1ccc2c(C(=O)Cl)c[nH]c2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.74
TUBB1 Q9H4B7 2/20 0.68
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
MITF O75030 1/20 0.57
LMNA P02545 1/20 0.57
RAB9A P51151 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
NR4A2 P43354 2/20 0.56
ALDH1A1 P00352 5/20 0.55
KDM4E B2RXH2 3/20 0.55
NPC1 O15118 1/20 0.55
ALOX15 P16050 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
GAA P10253 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HSD17B10 Q99714 1/20 0.53
CDK4 P11802 1/20 0.51
CCND1 P24385 1/20 0.51
PRKAB2 O43741 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1559431 0.88 MAPT (0.70) MAPTTUBB1MEN1KMT2AMITF
SCHEMBL11794897 0.88 LMNA (0.74) MAPTMEN1KMT2AMITFLMNA
SCHEMBL30075344 0.87 MAPT (0.73) MAPTTUBB1MEN1KMT2AMITF
SCHEMBL590922 0.87 MAPT (0.73) MAPTTUBB1MEN1KMT2AMITF
SCHEMBL12480809 0.86 MAPT (0.71) MAPTTUBB1MEN1KMT2AMITF
SCHEMBL27436910 0.85 MAPT (1.00) MAPTTUBB1MEN1KMT2AMITF
SCHEMBL3660284 0.84 MAPT (0.69) MAPTTUBB1MEN1KMT2AMITF
SCHEMBL31501108 0.84 NR4A2 (0.78) MAPTTUBB1MEN1KMT2ANPSR1
SCHEMBL4236223 0.84 NR4A2 (0.78) MAPTTUBB1MEN1KMT2ANPSR1
SCHEMBL1559335 0.83 MAPT (0.68) MAPTTUBB1MEN1KMT2AMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676929-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2026-01-14 EP disclosed
EP-4638447-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS Dark Blue Therapeutics Ltd (GB) 2025-10-29 EP disclosed
WO-2024188906-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 DARK BLUE THERAPEUTICS LTD (GB) 2024-09-19 WO disclosed
EP-4428134-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2024-09-11 EP disclosed
WO-2024133560-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS DARK BLUE THERAPEUTICS LTD (GB) 2024-06-27 WO disclosed
WO-2024133560-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS DARK BLUE THERAPEUTICS LTD (GB) 2024-06-27 WO disclosed
EP-4389747-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS Dark Blue Therapeutics Ltd (GB) 2024-06-26 EP disclosed